UNSPSC 51283505: Oxacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UH95VD7V76, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but generally known as oxacillin, which bears US NIH Compound Identifier 4608. European Medicines Agency schedules Oxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09484MIG.

UNSPSC 51283505 Oxacillin (Commodity) does not reflect the pharmaceutical products actually being procured in recent state and local opportunities under this code. The opportunities posted show procurement of Doxycycline Hyclate, Ciprofloxacin Hydrochloride, and Naloxone — not oxacillin — indicating a mismatch between the code's nominal scope and the work being bought. State and local health departments and county health agencies are using this code to procure pharmaceutical inventory through piggyback contracts and competitive bidding processes, with quarterly or bulk-order fulfillment models typical of public health supply chains.

Recent activity shows the Illinois Department of Public Health executing a completed piggyback award through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Bid Number 26482DPHPREPDB53392) for $2,999,999.11 over three years, and Seminole County, Florida issuing an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26 response deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually. The Seminole County procurement includes quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs borne by the vendor. Activity is concentrated in Florida and Illinois, though the code's taxonomy and recent opportunities do not align closely enough to support confident assessment of broader geographic or issuing-body patterns. Vendors pursuing opportunities under this code should verify alignment with specific pharmaceutical products requested in each solicitation rather than assuming the code name identifies the actual procurement.